Prevalence of Monoclonal Gammopathy of Undetermined Significance Among Men in Ghana
- A Unified Theory of the Causes of Monoclonal Gammopathy of Unknown Significance (MGUS) and Multiple Myeloma, with a Consequent Treatment Proposal for Long-Term Control and Possible Cure. Wheatley, Carmen // Journal of Orthomolecular Medicine;2002 1st Quarter, Vol. 17 Issue 1, p7
Investigates the causes of multiple myeloma and monoclonal gammopathy of unknown significance (MGUS). Background on epidemiological, biochemical and genetic causes; Hypothesis on the fundamental cause of MGUS and multiple myeloma; Proposals for long-term treatment and control.
- Monoclonal gammopathies in a Moroccan military hospital. Ouzzif, Z.; Doghmi, K.; Bouhsain, S.; Dami, A.; El Machtani, S.; Tellal, S.; Messaoudi, N.; Mikdame, M.; El Maataoui, A. // Rheumatology International;Oct2012, Vol. 32 Issue 10, p3303
The aim of this study was to describe biological features and aetiology of monoclonal gammopathy diagnosed during a 10-year period in the biochemistry department of the Moroccan Military Hospital Mohamed V in Rabat. The study was performed from 1 January 2000 to 31 December 2009. The records of...
- Prevalence of Monoclonal Gammopathy of Undetermined Significance: Study of 52,802 Persons in Nagasaki City, Japan. Iwanaca, Masako; Tagawa, Masuko; Tsukasaki, Kunihiro; Kamihira, Shimera; Tomonaga, Masao // Mayo Clinic Proceedings;Dec2007, Vol. 82 Issue 12, p1474
OBJECTIVE: To assess the prevalence of monoclonal gammopathy of undetermined significance (MGUS) In a large Japanese population. PARTICIPANTS AND METHODS: From October 1, 1988, to March 31, 2004, a total of 52,802 (of 71,675) Japanese survivors of the atomic bomb explosion in Nagasaki City,...
- Monoclonal Gammopathy of Undetermined Significance: Genetic vs Environmental Etiologies. Munshi, Nikhil C. // Mayo Clinic Proceedings;Dec2007, Vol. 82 Issue 12, p1457
The article presents the different study that asserts the prevalence and growth rate of monoclonal gamopathy of undetermined significance (MGUS). The study was administered in different population and countries with distinct environmental characteristics wherein ethnic differences and genetic...
- Protein Electrophoresis and Immunofixation for the Diagnosis of Monoclonal Gammopathies. Rajkumar, S. Vincent; Kyle, Robert A. // JAMA: Journal of the American Medical Association;11/26/2014, Vol. 312 Issue 20, p2160
The article reviews the application of urine protein electrophoresis and serum immunofixation in the case of a woman in her 70s who was diagnosed with monoclonal gammopathy of undetermined significance (MGUS). Data provided shows the patient's laboratory values and describes the characteristics...
- Neoplastic Plasma Cell. Berlin, Nathaniel I.; Merwin, Ruth; Potter, Michael; Fahey, John L.; Carbone, Paul P.; Cline, Martin J. // Annals of Internal Medicine;Jun63, Vol. 58 Issue 6, p1017
Discusses the etiology of plasma cell myeloma. Method of inducing plasma-cell tumors in mice; Assembly of diffusion chamber; Incidence of plasma-cell tumors.
- POEMS syndrome. // Taber's Cyclopedic Medical Dictionary;2005, p1701
A definition of the term "POEMS syndrome" is presented. It is rare multisystem disease characterized by the presence of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes. The cause of the condition is unknown. Crow-Fukase syndrome is the synonym of the term.
- Comparison of Hevyliteâ„¢ IgA and IgG assay with conventional techniques for the diagnosis and follow-up of plasma cell dyscrasia. Di Noto, Giuseppe; Maffina, Francesca; Martellosio, Giovanni; Radeghieri, Annalisa; Luigi, Caimi; Ricotta, Doris; Paolini, Lucia // Annals of Clinical Biochemistry;May2015, Vol. 52 Issue 3, p337
Background:Heavy/light chain assay allows the characterization and quantification of immunoglobulin light chains bound to heavy chains for each Ig'k and Ig' immunoglobulin class, discriminating between the involved/uninvolved isotypes in plasma cell dyscrasia. The Ig'k/Ig' ratio (heavy/light...
- Serum Immunoglobulin Free Light Chains in Patients with Monoclonal Gammapathies. Lubimova, N.; Turko, T.; Votyakova, O.; Kushlinskii, N. // Bulletin of Experimental Biology & Medicine;Jun2012, Vol. 153 Issue 2, p249
Serum concentrations of Îº- and Î»-free light chains and their ratios were compared in 126 patients with monoclonal gammapathies (age 23-80 years) and 60 normal subjects (25-82 years). The main group included patients with intact immunoglobulin multiple myeloma, Bence Jones multiple myeloma,...